1 CDC COVID data tracker. Centers for Disease Control & Prevention Web site.https://covid.cdc.gov/covid-data-tracker/#cases. Accessed 12/22/2020
2Figueiredo AM, Figueiredo DCMM, Gomes LB, et al. Social determinants of health and COVID-19 infection in Brazil: an analysis of the pandemic. Rev Bras Enferm. 2020;73(Suppl 2):e20200673. doi: http://dx.doi.org/10.1590/0034-7167-2020-0673
3Tobias A. Evaluation of the lockdowns for the SARS-CoV-2 epidemic in Italy and Spain after one month follow up. Sci Total Environ. 2020;725(10). doi: 10.1016/j.scitotenv.2020.138539
4Vahidy FS, Nicolas JC, Meeks JR, et al. Racial and ethnic disparities in SARS-CoV-2 pandemic: analysis of a COVID-19 observational registry for a diverse US metropolitan population. BMJ Open. 2020;10(8):e039849. Published 2020 Aug 11. doi:10.1136/bmjopen-2020-039849
5Newton S, Zollinger B, Freeman J, et al. Factors associated with clinical severity in Emergency Department patients presenting with symptomatic SARS-CoV-2 infection. medRxiv [Preprint]. 2020 Dec 11:2020.12.08.20246017. doi: 10.1101/2020.12.08.20246017. PMID: 33330879; PMCID: PMC7743088.
6Ogedegbe G, Ravenell J, Adhikari S, et al. Assessment of Racial/Ethnic Disparities in Hospitalization and Mortality in Patients With COVID-19 in New York City. JAMA Netw Open. 2020;3(12):e2026881. doi:10.1001/jamanetworkopen.2020.26881
7Elimian KO, Ochu CL, Ebhodaghe B, et al. Patient characteristics associated with COVID-19 positivity and fatality in Nigeria: retrospective cohort study. BMJ Open 2020;10:e044079. doi:10.1136/bmjopen-2020-044079
8Zhang J, Wang X, Jia X, et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect 2020;26:767–72.
9Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: a systematic review and meta-analysis. Int J Infect Dis 2020;94:91–5. doi:10.1016/j.ijid.2020.03.017
10United States Census Bureau: Quick Facts United States: https://www.census.gov/quickfacts/fact/table/US/PST045219
11County Health Rankings &Raodmaps https://www.countyhealthrankings.org/explore-health-ranking.
12Bahl A, Van Baalen MN, Ortiz L, et al. Early predictors of in-hospital mortality in patients with COVID-19 in a large American cohort. Intern Emerg Med. 2020 Nov;15(8):1485-1499. doi: 10.1007/s11739-020-02509-7. Epub 2020 Sep 24. PMID: 32970246; PMCID: PMC7512216.
13Nazroo J, Becares L. Evidence for ethnic inequalities in mortality related to COVID-19 infections: findings from an ecological analysis of England. BMJ Open 2020;10:e041750. doi:10.1136/bmjopen-2020-041750
14Goodman KE, Magder LS, Baghdadi JD, et al. Impact of Sex and Metabolic Comorbidities on COVID-19 Mortality Risk Across Age Groups: 66,646 Inpatients Across 613 U.S. Hospitals. Clin Infect Dis. 2020 Dec 18:ciaa1787. doi: 10.1093/cid/ciaa1787. Epub ahead of print. PMID: 33337474.
15Zhang J, Wang X, Jia X, et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan,China. Clin Microbiol Infect 2020;26:767–72.
16Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020 May;94:91-95. doi: 10.1016/j.ijid.2020.03.017. Epub 2020 Mar 12. PMID: 32173574; PMCID: PMC7194638.
17Speth MM, Singer-Cornelius T, Oberle M, Gengler I, Brockmeier SJ, Sedaghat AR. Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics. Otolaryngol Head Neck Surg. 2020 Jul;163(1):114-120. doi: 10.1177/0194599820929185. Epub 2020 May 19. PMID: 32423357; PMCID: PMC7240313.
18Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and prevention. JAMA. 2020. doi:10.1001/jama.2020.2648.
19Liu T, Liang W, Zhong H, et al. Risk factors associated with COVID-19 infection: a retrospective cohort study based on contacts tracing. Emerg Microbes Infect. 2020 Dec;9(1):1546-1553. doi: 10.1080/22221751.2020.1787799. PMID: 32608325; PMCID: PMC7473290.
20Oster AM, Caruso E, DeVies J, Hartnett KP, Boehmer TK. Transmission Dynamics by Age Group in COVID-19 Hotspot Counties - United States, April-September 2020. MMWR Morb Mortal Wkly Rep. 2020 Oct 16;69(41):1494-1496. doi: 10.15585/mmwr.mm6941e1. PMID: 33056949; PMCID: PMC7561089.
21Cheng HY, Jian SW, Liu DP, et al. Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset. JAMA Intern Med. 2020. doi:10.1001/jamainternmed.2020.2020.
22Rodriguez-Diaz CE, Guilamo-Ramos V, Mena L, et al. Risk for COVID-19 infection and death among Latinos in the United States: examining heterogeneity in transmission dynamics. Ann Epidemiol. 2020 Dec;52:46-53.e2. doi: 10.1016/j.annepidem.2020.07.007. Epub 2020 Jul 23. PMID: 32711053; PMCID: PMC7375962.
23Abu-Farha M, Al-Mulla F, Thanaraj TA, et al. (2020) Impact of Diabetes in Patients Diagnosed With COVID-19. Front. Immunol. 11:576818. doi: 10.3389/fimmu.2020.576818
24Wadhera RK, Wadhera P, Gaba P, et al. Variation in COVID-19 Hospitalizations and Deaths Across New York City Boroughs. JAMA. 2020 Jun 2;323(21):2192-2195. doi: 10.1001/jama.2020.7197. PMID: 32347898; PMCID: PMC7191469.